-
1
-
-
0027412216
-
High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients
-
Magriples, U., Naftolin, F., Schwartz, P. E., and Carcangiu, M. L. (1993) High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J. Clin. Oncol. 11, 485-490.
-
(1993)
J. Clin. Oncol.
, vol.11
, pp. 485-490
-
-
Magriples, U.1
Naftolin, F.2
Schwartz, P.E.3
Carcangiu, M.L.4
-
2
-
-
0027293895
-
Gynecologic tumors in tamoxifen-treated women with breast cancer
-
Seoud, M. A., Johnson, J., and Weed, J. C., Jr. (1993) Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet. Gynecol. 82, 165-169.
-
(1993)
Obstet. Gynecol.
, vol.82
, pp. 165-169
-
-
Seoud, M.A.1
Johnson, J.2
Weed Jr., J.C.3
-
3
-
-
0034989609
-
Understanding the genotoxicity of tamoxifen?
-
Phillips, D. H. (2001) Understanding the genotoxicity of tamoxifen? Carcinogenesis 22, 839-849.
-
(2001)
Carcinogenesis
, vol.22
, pp. 839-849
-
-
Phillips, D.H.1
-
4
-
-
0028208456
-
Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel project (NSABP) B-14
-
Fisher, B., Constantino, J. P., Redmond, C. K., Fisher, E. R., Wickerham, D. L., and Cronin, W. M. (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel project (NSABP) B-14. J. Natl. Cancer Inst. 86, 527-537.
-
(1994)
J. Natl. Cancer Inst.
, vol.86
, pp. 527-537
-
-
Fisher, B.1
Constantino, J.P.2
Redmond, C.K.3
Fisher, E.R.4
Wickerham, D.L.5
Cronin, W.M.6
-
5
-
-
0028053224
-
Risk of endometrial cancer after tamoxifen treatment of breast cancer
-
van Leeuwen, F. E., Benraadt, J., Coebergh, J. W., Kiemeney, L. A., Gimbrere, C. H., Otter, R., Schouten, L. J., Damhuis, R. A., Bontenbal, M., Diepenhorst, F. W., van den Belt-Dusebout, A. W., and van Tinteren, H. (1994) Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343, 448-452.
-
(1994)
Lancet
, vol.343
, pp. 448-452
-
-
Van Leeuwen, F.E.1
Benraadt, J.2
Coebergh, J.W.3
Kiemeney, L.A.4
Gimbrere, C.H.5
Otter, R.6
Schouten, L.J.7
Damhuis, R.A.8
Bontenbal, M.9
Diepenhorst, F.W.10
Van Den Belt-Dusebout, A.W.11
Van Tinteren, H.12
-
6
-
-
0029100925
-
Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers
-
Cook, L. S., Weiss, N. S., Schwartz, S. M., White, E., McKnight, B., Moore, D. E., and Daling, J. R. (1995) Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. J. Natl. Cancer Inst. 87, 1359-1364.
-
(1995)
J. Natl. Cancer Inst.
, vol.87
, pp. 1359-1364
-
-
Cook, L.S.1
Weiss, N.S.2
Schwartz, S.M.3
White, E.4
McKnight, B.5
Moore, D.E.6
Daling, J.R.7
-
7
-
-
0029964446
-
Endometrial carcinoma associated with breast carcinoma: Low incidence with tamoxifen use
-
Cuenca, R. E., Giachino, J., Arredondo, M. A., Hempling, R., and Edge, S. B. (1996) Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use. Cancer 77, 2058-2063.
-
(1996)
Cancer
, vol.77
, pp. 2058-2063
-
-
Cuenca, R.E.1
Giachino, J.2
Arredondo, M.A.3
Hempling, R.4
Edge, S.B.5
-
8
-
-
0030000097
-
Second cancers after adjuvant tamoxifen therapy for breast cancer
-
Curtis, R. E., Boice, J. D., Jr., Shriner, D. A., Hankey, B. F., and Fraumeni, J. F., Jr. (1996) Second cancers after adjuvant tamoxifen therapy for breast cancer. J. Natl. Cancer Inst. 88, 832-834.
-
(1996)
J. Natl. Cancer Inst.
, vol.88
, pp. 832-834
-
-
Curtis, R.E.1
Boice Jr., J.D.2
Shriner, D.A.3
Hankey, B.F.4
Fraumeni Jr., J.F.5
-
9
-
-
0027054733
-
Genotoxic potential of tamoxifen and analogues in female Fisher F344/n rats, DBA/2 and C57BL/6 and in human MCL-5 cells
-
White, I. N. H., de Matteis, F., Davies, A., Smith, L. L., Crofton-Sleigh, C., Venitt, S., Hewer, A., and Phillips, D. H. (1992) Genotoxic potential of tamoxifen and analogues in female Fisher F344/n rats, DBA/2 and C57BL/6 and in human MCL-5 cells. Carcinogenesis 13, 2197-2203.
-
(1992)
Carcinogenesis
, vol.13
, pp. 2197-2203
-
-
White, I.N.H.1
De Matteis, F.2
Davies, A.3
Smith, L.L.4
Crofton-Sleigh, C.5
Venitt, S.6
Hewer, A.7
Phillips, D.H.8
-
10
-
-
0026606580
-
Induction of covalent DNA adducts in rodents by tamoxifen
-
Han, X. L., and Liehr, J. G. (1992) Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res. 52, 1360-1363.
-
(1992)
Cancer Res.
, vol.52
, pp. 1360-1363
-
-
Han, X.L.1
Liehr, J.G.2
-
11
-
-
0028172454
-
Tamoxifen: Evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite
-
Randerath, K., Moorthy, B., Mabon, N., and Sriram, P. (1994) Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite. Carcinogenesis 15, 2087-2094.
-
(1994)
Carcinogenesis
, vol.15
, pp. 2087-2094
-
-
Randerath, K.1
Moorthy, B.2
Mabon, N.3
Sriram, P.4
-
12
-
-
0031949069
-
Synthesis and DNA reactivity of α-hydroxylated metabolites of nonsteroidal antiestrogens
-
Hardcastle, I. R., Horton, M. N., Osborne, M. R., Hewer, A., Jarman, M., and Phillips, D. H. (1998) Synthesis and DNA reactivity of α-hydroxylated metabolites of nonsteroidal antiestrogens. Chem. Res. Toxicol. 11, 369-374.
-
(1998)
Chem. Res. Toxicol.
, vol.11
, pp. 369-374
-
-
Hardcastle, I.R.1
Horton, M.N.2
Osborne, M.R.3
Hewer, A.4
Jarman, M.5
Phillips, D.H.6
-
13
-
-
0032519594
-
a-Hydroxytamoxifen is a substrate of hydroxysteroid (alcohol) sulfotransferase, resulting in tamoxifen DNA adducts
-
Shibutani, S., Dasaradhi, L., Terashima, I., Banoglu, E., and Duffel, M. W. (1998) a-Hydroxytamoxifen is a substrate of hydroxysteroid (alcohol) sulfotransferase, resulting in tamoxifen DNA adducts. Cancer. Res. 58, 647-653.
-
(1998)
Cancer. Res.
, vol.58
, pp. 647-653
-
-
Shibutani, S.1
Dasaradhi, L.2
Terashima, I.3
Banoglu, E.4
Duffel, M.W.5
-
14
-
-
0031054835
-
Identification of tamoxifen-DNA adducts formed by α-sulfate tamoxifen and α-acetoxy-tamoxifen
-
Dasaradhi, L., and Shibutani, S. (1997) Identification of tamoxifen-DNA adducts formed by α-sulfate tamoxifen and α-acetoxy-tamoxifen. Chem. Res. Toxicol. 10, 189-196.
-
(1997)
Chem. Res. Toxicol.
, vol.10
, pp. 189-196
-
-
Dasaradhi, L.1
Shibutani, S.2
-
15
-
-
0029866506
-
Evidence that the catechol 3,4-dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins
-
Dehal, S. S., and Kupfer, D. (1996) Evidence that the catechol 3,4-dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins. Cancer Res. 56, 1283-1290.
-
(1996)
Cancer Res.
, vol.56
, pp. 1283-1290
-
-
Dehal, S.S.1
Kupfer, D.2
-
16
-
-
0033017135
-
Cytochrome P450 3A and 2D6 catalyze ortho hydroxylation of 4-hydroxytamoxifen and 3-hy-droxytamoxifen (droloxifene) yielding tamoxifen catechol: Involvement of catechols in covalent binding to hepatic proteins
-
Dehal, S. S., and Kupfer, D. (1999) Cytochrome P450 3A and 2D6 catalyze ortho hydroxylation of 4-hydroxytamoxifen and 3-hy-droxytamoxifen (droloxifene) yielding tamoxifen catechol: involvement of catechols in covalent binding to hepatic proteins. Drug Metab. Dispos. 27, 681-688.
-
(1999)
Drug Metab. Dispos.
, vol.27
, pp. 681-688
-
-
Dehal, S.S.1
Kupfer, D.2
-
17
-
-
0033065364
-
Comparison of the DNA adducts formed by tamoxifen and 4-hydroxytamoxifen in vivo
-
Beland, F. A., McDaniel, L. P., and Marques, M. M. (1999) Comparison of the DNA adducts formed by tamoxifen and 4-hydroxytamoxifen in vivo. Carcinogenesis 20, 471-477.
-
(1999)
Carcinogenesis
, vol.20
, pp. 471-477
-
-
Beland, F.A.1
McDaniel, L.P.2
Marques, M.M.3
-
18
-
-
0032974948
-
4-Hydroxytamoxifen gives DNA adducts by chemical activation, but not in rat liver cells
-
Osborne, M. R., Davis, W., Hewer, A. J., Hardcastle, I. R., and Phillips, D. H. (1999) 4-Hydroxytamoxifen gives DNA adducts by chemical activation, but not in rat liver cells. Chem. Res. Toxicol. 12, 151-158.
-
(1999)
Chem. Res. Toxicol.
, vol.12
, pp. 151-158
-
-
Osborne, M.R.1
Davis, W.2
Hewer, A.J.3
Hardcastle, I.R.4
Phillips, D.H.5
-
19
-
-
0031416520
-
Identification of tamoxifen-DNA adducts by 4-hydroxytamoxifen quinone methide
-
Marques, M. M., and Beland, F. A. (1997) Identification of tamoxifen-DNA adducts by 4-hydroxytamoxifen quinone methide. Carcinogenesis 18, 1949-1954.
-
(1997)
Carcinogenesis
, vol.18
, pp. 1949-1954
-
-
Marques, M.M.1
Beland, F.A.2
-
20
-
-
0021201213
-
Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4- hydroxyphenyl)benzo[b] thien-3-yl] [4-[2-(1-piperidinyl)ethoxylphenyl]methanone hydrochloride (LY156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity
-
Jones, C. D., Jevnikar, M. G., Pike, A. J., Peters, M. K., Black, L. J., Thompson, A. R., Falcone, J. F., and Clemens, J. A. (1984) Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b] thien-3-yl] [4-[2-(1-piperidinyl)ethoxylphenyl]methanone hydrochloride (LY156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity. J. Med. Chem. 27, 1057-1066.
-
(1984)
J. Med. Chem.
, vol.27
, pp. 1057-1066
-
-
Jones, C.D.1
Jevnikar, M.G.2
Pike, A.J.3
Peters, M.K.4
Black, L.J.5
Thompson, A.R.6
Falcone, J.F.7
Clemens, J.A.8
-
21
-
-
0021248131
-
Nonsteroidal antioestrogens-receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells
-
Wakeling, A. E., Valcaccia, B., Newboult, E., and Green, L. R. (1984) Nonsteroidal antioestrogens-receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells. J. Steroid Biochem. 20, 111-120.
-
(1984)
J. Steroid Biochem.
, vol.20
, pp. 111-120
-
-
Wakeling, A.E.1
Valcaccia, B.2
Newboult, E.3
Green, L.R.4
-
22
-
-
0020582094
-
Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levels
-
Clemens, J. A., Bennett, D. R., Black, L. J., and Jones, C. D. (1983) Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levels. Life Sci. 32, 2869-2875.
-
(1983)
Life Sci.
, vol.32
, pp. 2869-2875
-
-
Clemens, J.A.1
Bennett, D.R.2
Black, L.J.3
Jones, C.D.4
-
23
-
-
0036718266
-
The Study of Tamoxifen and Raloxifene (STAR trial) for the prevention of breast cancer
-
Kelminski, A. (2002) The Study of Tamoxifen and Raloxifene (STAR trial) for the prevention of breast cancer. Hawaii Med. J. 61, 209-210.
-
(2002)
Hawaii Med. J.
, vol.61
, pp. 209-210
-
-
Kelminski, A.1
-
24
-
-
0035996330
-
Cytochrome P450 3A4-mediated bioactivation of raloxifene: Irreversible enzyme inhibition and thiol adduct formation
-
Chen, Q., Ngui, J. S., Doss, G. A., Wang, R. W., Cai, X., DiNinno, F. P., Blizzard, T. A., Hammond, M. L., Stearns, R. A., Evans, D. C., Baillie, T. A., and Tang, W. (2002) Cytochrome P450 3A4-mediated bioactivation of raloxifene: irreversible enzyme inhibition and thiol adduct formation. Chem. Res. Toxicol. 15, 907-914.
-
(2002)
Chem. Res. Toxicol.
, vol.15
, pp. 907-914
-
-
Chen, Q.1
Ngui, J.S.2
Doss, G.A.3
Wang, R.W.4
Cai, X.5
DiNinno, F.P.6
Blizzard, T.A.7
Hammond, M.L.8
Stearns, R.A.9
Evans, D.C.10
Baillie, T.A.11
Tang, W.12
-
25
-
-
0023585268
-
Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice
-
Thompson, J. A., Malkinson, A. M., Wand, M. D., Mastovich, S. L., Mead, E. W., Schullek, K. M., and Laudenschlager, W. G. (1987) Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice. Drug Metab. Dispos. 15, 833-840.
-
(1987)
Drug Metab. Dispos.
, vol.15
, pp. 833-840
-
-
Thompson, J.A.1
Malkinson, A.M.2
Wand, M.D.3
Mastovich, S.L.4
Mead, E.W.5
Schullek, K.M.6
Laudenschlager, W.G.7
-
26
-
-
0007522011
-
Stereochemistry and reactions with hydroxyl ion and with silver oxide of the 2-bromo-4-phenylcyclohexanols and the 1-methyl-2-bromo-4-phenylcyclohexanols
-
Curtin, D. Y., and Harder, R. J. (1960) Stereochemistry and reactions with hydroxyl ion and with silver oxide of the 2-bromo-4-phenylcyclohexanols and the 1-methyl-2-bromo-4-phenylcyclohexanols. J. Am. Chem. Soc. 82, 2357-2368.
-
(1960)
J. Am. Chem. Soc.
, vol.82
, pp. 2357-2368
-
-
Curtin, D.Y.1
Harder, R.J.2
-
28
-
-
3042794987
-
Quinoids formed from estrogens and antiestrogens
-
Bolton, J. L., Yu, L., and Thatcher, G. R. J. (2004) Quinoids formed from estrogens and antiestrogens. Methods Enzymol. 378, 110-123.
-
(2004)
Methods Enzymol.
, vol.378
, pp. 110-123
-
-
Bolton, J.L.1
Yu, L.2
Thatcher, G.R.J.3
-
29
-
-
0027205012
-
Mass spectrometry in the analysis of glutathione conjugates
-
Baillie, T. A., and Davis, M. R. (1993) Mass spectrometry in the analysis of glutathione conjugates. Biol. Mass Spectrom. 22, 319-325.
-
(1993)
Biol. Mass Spectrom.
, vol.22
, pp. 319-325
-
-
Baillie, T.A.1
Davis, M.R.2
-
30
-
-
0142200899
-
Nitrosation, nitration, and autoxidation of the selective estrogen receptor modulator raloxifene by nitric oxide, peroxynitrite, and reactive nitrogen/oxygen species
-
Toader, V., Xu, X., Nicolescu, A., Yu, L., Bolton, J. L., and Thatcher, G. R. (2003) Nitrosation, nitration, and autoxidation of the selective estrogen receptor modulator raloxifene by nitric oxide, peroxynitrite, and reactive nitrogen/oxygen species. Chem. Res. Toxicol. 16, 1264-1276.
-
(2003)
Chem. Res. Toxicol.
, vol.16
, pp. 1264-1276
-
-
Toader, V.1
Xu, X.2
Nicolescu, A.3
Yu, L.4
Bolton, J.L.5
Thatcher, G.R.6
-
31
-
-
0037255847
-
Pharmacokinetics of selective estrogen receptor modulators
-
Morello, K. C., Wurz, G. T., and DeGregorio, M. W. (2003) Pharmacokinetics of selective estrogen receptor modulators. Clin. Pharmacokinet. 42, 361-372.
-
(2003)
Clin. Pharmacokinet.
, vol.42
, pp. 361-372
-
-
Morello, K.C.1
Wurz, G.T.2
DeGregorio, M.W.3
-
32
-
-
0034666239
-
Raloxifene hydrochloride
-
Snyder, K. R., Sparano, N., and Malinowski, J. M. (2000) Raloxifene hydrochloride. Am. J. Health-Syst. Pharm. 57, 1669-1675.
-
(2000)
Am. J. Health-Syst. Pharm.
, vol.57
, pp. 1669-1675
-
-
Snyder, K.R.1
Sparano, N.2
Malinowski, J.M.3
-
33
-
-
0033062743
-
Pharmacokinetics of raloxifene and its clinical application
-
Hochner-Celnikier, D. (1999) Pharmacokinetics of raloxifene and its clinical application. Eur. J. Obstet. Gynecol. Reprod. Biol. 85, 23-29.
-
(1999)
Eur. J. Obstet. Gynecol. Reprod. Biol.
, vol.85
, pp. 23-29
-
-
Hochner-Celnikier, D.1
-
34
-
-
0033046884
-
Rapid drug metabolite profiling using fast liquid chromatography, automated multiple-stage mass spectrometry and receptor-binding
-
Lim, H. K., Stellingweif, S., Sisenwine, S., and Chan, K. W. (1999) Rapid drug metabolite profiling using fast liquid chromatography, automated multiple-stage mass spectrometry and receptor-binding. J Chromatogr. A 831, 227-241.
-
(1999)
J Chromatogr. A
, vol.831
, pp. 227-241
-
-
Lim, H.K.1
Stellingweif, S.2
Sisenwine, S.3
Chan, K.W.4
-
35
-
-
0033489866
-
Estrogen synthesis in human colon cancer epithelial cells
-
Fiorelli, G., Picariello, L., Martineti, V., Tonelli, F., and Brandi, M. L. (1999) Estrogen synthesis in human colon cancer epithelial cells. J. Steroid Biochem. Mol. Biol. 71, 223-230.
-
(1999)
J. Steroid Biochem. Mol. Biol.
, vol.71
, pp. 223-230
-
-
Fiorelli, G.1
Picariello, L.2
Martineti, V.3
Tonelli, F.4
Brandi, M.L.5
-
36
-
-
0028930981
-
o-Methoxy-4-alkylphenols that form quinone methides of intermediate reactivity are the most toxic in rat liver slices
-
Thompson, D. C., Perera, K., Krol, E. S., and Bolton, J. L. (1995) o-Methoxy-4-alkylphenols that form quinone methides of intermediate reactivity are the most toxic in rat liver slices. Chem. Res. Toxicol. 8, 323-327.
-
(1995)
Chem. Res. Toxicol.
, vol.8
, pp. 323-327
-
-
Thompson, D.C.1
Perera, K.2
Krol, E.S.3
Bolton, J.L.4
-
37
-
-
15644370745
-
Structure-activity relationships of selective estrogen receptor modulators: Modifications to the 2-arylbenzothiophene core of raloxifene
-
Grese, T. A., Cho, S., Finley, D. R., Godfrey, A. G., Jones, C. D., Lugar, C. W., 3rd, Martin, M. J., Matsumoto, K., Pennington, L. D., Winter, M. A., Adrian, M. D., Cole, H. W., Magee, D. E., Phillips, D. L., Rowley, E. R., Short, L. L., Glasebrook, A. L., and Bryant, H. U. (1997) Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene. J. Med. Chem. 40, 146-167.
-
(1997)
J. Med. Chem.
, vol.40
, pp. 146-167
-
-
Grese, T.A.1
Cho, S.2
Finley, D.R.3
Godfrey, A.G.4
Jones, C.D.5
Lugar III, C.W.6
Martin, M.J.7
Matsumoto, K.8
Pennington, L.D.9
Winter, M.A.10
Adrian, M.D.11
Cole, H.W.12
Magee, D.E.13
Phillips, D.L.14
Rowley, E.R.15
Short, L.L.16
Glasebrook, A.L.17
Bryant, H.U.18
-
38
-
-
1642270595
-
Isomerization of 3-substituted indoles, benzofurans, and benzo[b]thiophenes
-
Kost, A. N., Budylin, V. A., Matveeva, E. D., and Sterligov, D. O. (1970) Isomerization of 3-substituted indoles, benzofurans, and benzo[b]thiophenes. Zh. Org. Khim. 6, 1516-1517.
-
(1970)
Zh. Org. Khim.
, vol.6
, pp. 1516-1517
-
-
Kost, A.N.1
Budylin, V.A.2
Matveeva, E.D.3
Sterligov, D.O.4
-
39
-
-
0034035343
-
A metabolite of equine estrogens, 4-hydroxyequilenin, induces DNA damage and apoptosis in breast cancer cell lines
-
Chen, Y., Liu, X., Pisha, E., Constantinou, A. I., Hua, Y., Shen, L., van Breemen, R. B., Elguindi, E. C., Blond, S. Y., Zhang, F., and Bolton, J. L. (2000) A metabolite of equine estrogens, 4-hydroxyequilenin, induces DNA damage and apoptosis in breast cancer cell lines. Chem. Res. Toxicol. 13, 342-350.
-
(2000)
Chem. Res. Toxicol.
, vol.13
, pp. 342-350
-
-
Chen, Y.1
Liu, X.2
Pisha, E.3
Constantinou, A.I.4
Hua, Y.5
Shen, L.6
Van Breemen, R.B.7
Elguindi, E.C.8
Blond, S.Y.9
Zhang, F.10
Bolton, J.L.11
|